The Irish medicines verification system will be funded by fees paid by marketing authorisation (MA) holders whose product data will be held in the national repository. IMVO’s running costs will be also funded by MA holder fees, with a contribution from subscriptions paid by IMVO’s member organisations.  

MA holders, wholesalers and pharmacies have to pay the costs of their own internal changes, including changing packaging, installing scanners, upgrading software systems, etc.